SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report: March 31, 2004
Commission File Number: 000-18053
LASERSCOPE
(Exact name of Registrant as specified in its charter)
CALIFORNIA 77-0049527
(State or other jurisdiction of (I.R.S. Employer Identification No.)
incorporation or organization)
3070 ORCHARD DRIVE
SAN JOSE, CA 95134-2011
(Address of principal executive offices)
(408) 943-0636
(Registrant's telephone number, including area code)
NOT APPLICABLE
(Former name or former address, if changed since last report)
ITEM 5. OTHER EVENTS
On March 31, 2004, Laserscope issued a press release announcing the details of
the new, higher reimbursement rate for the company's GreenLight PVP(TM)
treatment for enlarged prostate. A copy of the release is attached as Exhibit
99.1 and incorporated by reference herein.
ITEM 7(c). EXHIBITS
99.1 Press release dated March 31, 2004.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
LASERSCOPE
(Registrant)
Date: March 31, 2004 By: /s/ Dennis LaLumandiere
-------------------------------------
Dennis LaLumandiere
Vice President, Finance,
Chief Financial Officer and Secretary
INDEX TO EXHIBITS
EXHIBIT
NUMBER DESCRIPTION
- ------- -----------------------------------
99.1 PRESS RELEASE DATED MARCH 31, 2004.